Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1?

Clinical Microbiology and Infection

Volumn 23, Issue 9, 2017, Pages 676.e1-676.e5

  Dobias, J ^a   Poirel, L ^a,b   Nordmann, P ^a,b,c  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b National Reference Center for Emerging Antibiotic Resistance   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

colistin; defensins; Enterobacteriaceae; Escherichia coli; Klebsiella pneumoniae; MCR 1

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 5; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATIONIC ANTIMICROBIAL PEPTIDE; COLISTIN; ETHANOLAMINE PHOSPHOTRANSFERASE; LIPOPOLYSACCHARIDE; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ARTICLE; BACTERIAL STRAIN; CROSS RESISTANCE; ESCHERICHIA COLI; GENE; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MCR 1 GENE; NONHUMAN; PLASMID; PRIORITY JOURNAL; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; KLEBSIELLA INFECTION; MICROBIOLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; POLYMYXINS;

EID: 85019110992     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2017.03.015     Document Type: Article

References (20)

1. Zavascki, A.P., Goldani, L.Z., Li, J., Nation, R.L., Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60 (2007), 1206–1215.
2. Bialvaei, A.Z., Samadi Kafil, H., Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 31 (2015), 707–721.
3. Band, V.I., Weiss, D.S., Mechanisms of antimicrobial peptide resistance in Gram-negative bacteria. Antibiotics 4 (2015), 18–41.
4. Liu, Y.Y., Wang, Y., Walsh, T.R., Yi, L.X., Zhang, R., Spencer, J., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16 (2016), 161–168.
5. Nordmann, P., Poirel, L., Plasmid-mediated colistin resistance; an additional antibiotic resistance menace. Clin Microbiol Infect 22 (2016), 398–400.
6. Hancock, R.E.W., Diamond, G., The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8 (2000), 402–410.
7. Andersson, D.I., Hughes, D., Kubicek-Sutherland, J.Z., Mechanisms and consequence of bacterial resistance of antimicrobial peptides. Drug Resist Updat 26 (2016), 43–57.
8. Napier, B.A., Burd, E.M., Satola, S.W., Cagle, S.M., Ray, S.M., McGann, P., et al. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii. mBio, 4, 2013 e00021–13.
9. Trombley, M.P., Post, D.M.B., Rinker, S.D., Reinders, L.M., Fortney, K.R., Zwickl, B.W., et al. Phosphoethanolamine transferase LptA in Haemophilus ducreyi modifies lipid A and contributes to human defensin resistance in vitro. PLoS One, 10, 2015, e0124373.
10. Cullen, T.W., Madsen, J.A., Ivanov, P.L., Brodbelt, J.S., Trent, M.S., Characterization of unique modification of flagellar rod protein FlgG by Campylobacter jejuni/lipidA phosphoethanolamine transferase, linking bacterial locomotion and antimicrobial peptide resistance. J Biol Chem 287 (2012), 3326–3336.
11. Thennarasu, S., Tan, A., Penumatchu, R., Shelburne, C.E., Heyl, D.L., Ramamoorthy, A., Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys J 98 (2010), 248–257.
12. Vandamme, D., Landuyt, B., Luyten, W., Schoofs, L., A comprehensive summary of LL-37, the factoctum human cathelicidin peptide. Cell Immunol 280 (2012), 22–35.
13. Dhople, V., Krukemeyer, A., Ramamoorthy, A., The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta – Biomembranes 1758 (2006), 1499–1512.
14. Poirel, L., Kieffer, N., Brink, A., Coetze, J., Jayol, A., Nordmann, P., Genetic features of MCR-1-producing colistin-resistant Escherichia coli isolates, South Africa. Antimicrob Agents Chemother 60 (2016), 4394–4397.
15. Nordmann, P., Jayol, A., Poirel, L., A universal culture medium for screening polymyxin-resistant Gram-negative isolates. J Clin Microbiol 54 (2016), 1395–1399.
16. Mount, K.L.B., Carisa, A., Bauer, T., Bauer, M.E., Haemophilus ducreyi is resistant to human antimicrobial peptides. Antimicrob Agents Chemother 51 (2007), 3391–3393.
17. Rinker, S.D., Trombley, M.P., Gu, X.P., Fortney, K.R., Bauer, M.E., Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon. Infect Immunity 79 (2011), 2324–2334.
18. European Committee on Antimicrobial Susceptibility Testing (EUCAST), Breakpoints tables for interpretation of MICs and zone diameters, Version 2.0: The Committee. 2014.
19. Kao, C., Lin, X., Yi, G., Zhang, Y., Rowe-Magnus, D.A., Bush, K., Cathelicidin antimicrobial peptides with reduced activation of Toll-like receptor signaling have potent bactericidal activity against colistin-resistant bacteria. mBio, 7, 2016 e01418–16.
20. Sherman, E.X., Hufnagel, D.A., Weiss, D.S., MCR-1 confers cross-resistance to lysozyme. Lancet Infect Dis 16 (2016), 1226–1227.